Market Overview

Benzinga's Top Initiations

Benzinga's Top Initiations
Related ALXN
5 Stocks With Potential To Rally 12% Or More, According To Analysts
7 Largest Price Target Changes For Monday
More Data From Alnylam Pharmaceuticals, But Not Much More Clarity (Seeking Alpha)
Related DHR
Danaher Poised To Deliver Continued Sales Growth, Says Argus
The Time May Be Right To Look At Roper Technologies
Smith & Nephew Continues To Impress (Seeking Alpha)

Analysts at Citigroup initiated coverage on shares of Alexion Pharmaceuticals (NASDAQ: ALXN) with a “neutral” rating. Alexion's shares closed at $93.59 yesterday. Alexion's trailing-twelve-month operating margin is 35.20%.

BMO Capital initiated coverage on shares of Danaher (NYSE: DHR) with an “outperform” rating. Danaher's shares closed at $53.07 yesterday. Danaher's trailing-twelve-month revenue is $18.00 billion.

SunTrust initiated coverage on shares of Citigroup (NYSE: C) with a “buy” rating. Citigroup's stock closed at $37.02 yesterday. Citigroup had $798.78 billion in total cash for the recent quarter.

Analysts at Wedbush initiated coverage on shares of Oracle (NASDAQ: ORCL) with a “neutral” rating. Oracle's shares closed at $32.03 yesterday. Oracle's PEG ratio is 1.00.

Latest Ratings for ALXN

Jul 2016RBC CapitalInitiates Coverage onOutperform
Jul 2016Credit SuisseUpgradesNeutralOutperform
Jun 2016CitigroupUpgradesNeutralBuy

View More Analyst Ratings for ALXN
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings


Related Articles (ALXN + C)

View Comments and Join the Discussion!